These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19247033)

  • 1. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer.
    Chen JH; Feig BA; Hsiang DJ; Butler JA; Mehta RS; Bahri S; Nalcioglu O; Su MY
    Ann Surg; 2009 Mar; 249(3):448-54. PubMed ID: 19247033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
    Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
    Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.
    Cheung YC; Chen SC; Su MY; See LC; Hsueh S; Chang HK; Lin YC; Tsai CS
    Breast Cancer Res Treat; 2003 Mar; 78(1):51-8. PubMed ID: 12611457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for Mastectomy after Neoadjuvant Chemotherapy.
    Gusic LH; Walsh K; Flippo-Morton T; Sarantou T; Boselli D; White RL
    Am Surg; 2018 Jan; 84(1):126-132. PubMed ID: 29428039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
    Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
    BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.
    Sutton EJ; Braunstein LZ; El-Tamer MB; Brogi E; Hughes M; Bryce Y; Gluskin JS; Powell S; Woosley A; Tadros A; Sevilimedu V; Martinez DF; Toni L; Smelianskaia O; Nyman CG; Razavi P; Norton L; Fung MM; Sedorovich JD; Sacchini V; Morris EA
    JAMA Netw Open; 2021 Jan; 4(1):e2034045. PubMed ID: 33449096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.
    Straver ME; Loo CE; Rutgers EJ; Oldenburg HS; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
    Ann Surg; 2010 Apr; 251(4):701-7. PubMed ID: 20224378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
    Kantor O; Ajmani G; Wang CH; Datta A; Yao K
    Ann Surg Oncol; 2018 Jan; 25(1):164-172. PubMed ID: 29127538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].
    Brisson C; Diguisto C; Vildé A; Body G; Arbion F; Leveque J; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):147-154. PubMed ID: 28403971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
    Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
    Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Choi JS; Ko ES; Ko EY; Han BK; Nam SJ
    Medicine (Baltimore); 2016 Mar; 95(9):e3000. PubMed ID: 26945421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
    McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
    Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy.
    Chen JH; Feig B; Agrawal G; Yu H; Carpenter PM; Mehta RS; Nalcioglu O; Su MY
    Cancer; 2008 Jan; 112(1):17-26. PubMed ID: 18000804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
    Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
    Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of the multidisciplinary team in the decision-making process of patients undergoing neoadjuvant chemotherapy for breast cancer.
    Fancellu A; Pasqualitto V; Cottu P; Giuliani G; Grasso L; Ariu ML; Porcu A; Sanna V
    Updates Surg; 2024 Sep; 76(5):1919-1926. PubMed ID: 38315320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
    Choi BB; Kim SH
    Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Li X; Yan C; Xiao J; Xu X; Li Y; Wen X; Wei H
    Clin Breast Cancer; 2021 Oct; 21(5):e611-e617. PubMed ID: 34001440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
    Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
    Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
    Eom HJ; Cha JH; Choi WJ; Chae EY; Shin HJ; Kim HH
    AJR Am J Roentgenol; 2017 Jun; 208(6):W225-W230. PubMed ID: 28350486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.